NCT07524855
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07524855
Title A Study of HLD-0117 in Patients With Metastatic Breast Cancer (HLD-0117)
Acronym HLD-0117
Recruitment Recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors Halda Therapeutics OpCo, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.